Adding Pressure BioSciences (PBIO) $0.80 to Watch List.

Long Time Coming, Pressure Bio Reaches Turning Point. Science Finally Meets Revenues. Photo Ric Schumacher CEO
Revive Therapeutics

Revive Therapeutics (RVVTF) Moves a Step Closer to FDA Verdict for Its Novel Covid...

Two Binary Events Directly Ahead. As in Months Away, not Years. Share Price up 76% During April.

Surna Cultivation Technologies Signs Contract for New Addition to Product Portfolio

Converted Air Sanitization Product Partnership to Customer Contract in Under Thirty Days Louisville, Colorado, April 05, 2022 (GLOBE NEWSWIRE) -- CEA Industries...
CEA Industries

Surna Cultivation Technologies Signs $2.1 Million Contract

This is the 4th Multi-Million Contract Awarded in the Last Couple Years, With Three in 2022 Alone!

The Race to Develop Therapeutics for COVID. The Small Caps Fight for a Treatment...

The Second Wave: Biopharma Players Race to Develop Therapeutics for COVID-19 (BioSPace) December 21. Revive Therapeutics (RVTTF), RedHill BioPharma...

Latest article

Post Reverse Split, Tharimmune (THAR) Announces Positive Phase I Results.

This is a story of 're-purposed' FDA approved drug, from drug overdose, to a solution for unrelenting itching. If approved, it can...

Trump’s (DJT) up 48% Today

LIVE QUOTE Our only thought is it would be a great idea, to give...

Altamira Thera (CYTO) Explodes 144% Higher Post Reverse Split, With 50 Million Shares Trading...

Taking advantage of post reverse-split investor pessimism, is a VALID investing technique. Altamira is developing and supplying peptide-based...